Nothing Special   »   [go: up one dir, main page]

NO963331L - 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister - Google Patents

5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister

Info

Publication number
NO963331L
NO963331L NO963331A NO963331A NO963331L NO 963331 L NO963331 L NO 963331L NO 963331 A NO963331 A NO 963331A NO 963331 A NO963331 A NO 963331A NO 963331 L NO963331 L NO 963331L
Authority
NO
Norway
Prior art keywords
antagonists
receptor site
benzodiazepine receptor
site agonists
heteroarylindole
Prior art date
Application number
NO963331A
Other languages
English (en)
Other versions
NO963331D0 (no
Inventor
John E Macor
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO963331D0 publication Critical patent/NO963331D0/no
Publication of NO963331L publication Critical patent/NO963331L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)

Abstract

Foreliggende oppfinnelse angår forbindelser med formel (I). Oppfinnelsen angår også mellomprodukter for fremstilling av forbindelser med formel (I), farmasøytiske preparater som inneholder disse, samt fremgangsmåter for deres anvendelse.
NO963331A 1994-02-10 1996-08-09 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister NO963331L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19455394A 1994-02-10 1994-02-10
PCT/IB1994/000407 WO1995021836A1 (en) 1994-02-10 1994-12-08 5-heteroarylindole derivatives as benzodiazepine receptor site agonists and antagonists

Publications (2)

Publication Number Publication Date
NO963331D0 NO963331D0 (no) 1996-08-09
NO963331L true NO963331L (no) 1996-10-09

Family

ID=22718035

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963331A NO963331L (no) 1994-02-10 1996-08-09 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister

Country Status (12)

Country Link
US (1) US5688809A (no)
EP (1) EP0743942A1 (no)
JP (1) JP2829788B2 (no)
KR (1) KR970701182A (no)
CN (1) CN1067386C (no)
AU (1) AU685881B2 (no)
CA (1) CA2183084A1 (no)
FI (1) FI950568A (no)
IL (1) IL112519A0 (no)
NO (1) NO963331L (no)
NZ (1) NZ276172A (no)
WO (1) WO1995021836A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ502642A (en) * 1997-07-03 2002-06-28 Du Pont Pharm Co Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
US6365589B1 (en) 1998-07-02 2002-04-02 Bristol-Myers Squibb Pharma Company Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
UA82395C2 (en) * 2003-08-21 2008-04-10 Оси Фармасьютикалз, Инк. N-substituted benzimidazolyl c-kit inhibitors
US7442709B2 (en) * 2003-08-21 2008-10-28 Osi Pharmaceuticals, Inc. N3-substituted imidazopyridine c-Kit inhibitors
CN1839130A (zh) 2003-08-21 2006-09-27 Osi制药公司 N－取代的吡唑基－酰胺基－苯并咪唑基的c－kit抑制剂
JP2008521903A (ja) * 2004-12-01 2008-06-26 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド Ｎ置換されたベンズイミダゾリルＣ−ｋｉｔ阻害剤及びコンビナトリアルベンゾイミダゾールライブラリー
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
US9394285B2 (en) 2013-03-15 2016-07-19 Pfizer Inc. Indole and indazole compounds that activate AMPK
JP6800885B2 (ja) 2015-04-29 2020-12-16 ヤンセン ファーマシューティカ エヌ．ベー． イミダゾピラジン及びピラゾロピリミジン、並びにａｍｐａ受容体調節物質としてのこれらの使用
US10611730B2 (en) 2015-04-29 2020-04-07 Janssen Pharmaceutica Nv Benzimidazolone and benzothiazolone compounds and their use as AMPA receptor modulators
SG11201708190UA (en) 2015-04-29 2017-11-29 Janssen Pharmaceutica Nv Azabenzimidazoles and their use as ampa receptor modulators
EP3288935B1 (en) 2015-04-29 2019-10-30 Janssen Pharmaceutica NV Indolone compounds and their use as ampa receptor modulators
KR101831553B1 (ko) 2017-01-23 2018-02-22 계명대학교 산학협력단 전이성 유방암의 유용한 신규 화합물 및 이의 의학적 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066654A (en) * 1990-10-22 1991-11-19 A. H. Robins Company, Incorporated 2-aryl-3-heterocyclicmethyl-3H-imidazo[4,5-b]pyridines as anxiolytics and anticonvulsants
GB9210400D0 (en) * 1992-05-15 1992-07-01 Merck Sharp & Dohme Therapeutic agents
TW251284B (no) * 1992-11-02 1995-07-11 Pfizer

Also Published As

Publication number Publication date
FI950568A (fi) 1995-08-11
CA2183084A1 (en) 1995-08-17
WO1995021836A1 (en) 1995-08-17
IL112519A0 (en) 1995-05-26
AU685881B2 (en) 1998-01-29
KR970701182A (ko) 1997-03-17
NZ276172A (en) 1998-02-26
US5688809A (en) 1997-11-18
EP0743942A1 (en) 1996-11-27
NO963331D0 (no) 1996-08-09
JP2829788B2 (ja) 1998-12-02
CN1142823A (zh) 1997-02-12
AU1033995A (en) 1995-08-29
JPH09501949A (ja) 1997-02-25
FI950568A0 (fi) 1995-02-09
CN1067386C (zh) 2001-06-20

Similar Documents

Publication Publication Date Title
DK0889877T3 (da) Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer
NO20022095L (no) Heterocyklisk substituerte pyrazoloner
ES2154167A1 (es) Aminoderivados ciclicos antagonistas del receptor ccr-3.
NO20032905D0 (no) Nye benzodiazepiner og beslektede heterocykliske derivater som er anvendelige som orexinreseptorantagonister
EA199700156A1 (ru) Производные индола как антагонисты рецептора 5-нт
WO2002098856A3 (en) Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
BR0015963A (pt) Compostos de uréia antagonistas receptor muscarìnico, composições farmacêuticas compreendendo tais compostos e método de preparação destes compostos
YU16899A (sh) Aralkil i aralkiliden heterociklicni laktami i imidi
NO983002L (no) Vitronectin-reseptor-antagonister
WO1999002502A3 (en) Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation
ATE267200T1 (de) Bicyclische kinase inhibitoren
NO20034230D0 (no) 1,2,3,4-tetrahydroisokinolin-derivater som urotensin II reseptor-antagonister
PT1274687E (pt) Derivados de 1,2,3,4-tetra-hidroisoquinolina
DK0641328T3 (da) Broforbundne, azabicykliske derivater som substans P-antagonister
TR200101398T2 (tr) Pirolidin türevleri-CCR-3 reseptörü antagonistleri.
PA8484201A1 (es) Derivados de adenina
ATE301653T1 (de) Pyrazolopyridine
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
BR9915735A (pt) Antagonistas receptores de ccr-3 de piperidina
ATE293448T1 (de) Benzo(d)azepin-derivative als 5-ht6-rezeptor- antagonisten
ATE300541T1 (de) Pyrazolopyridinderivate
NO963331L (no) 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister
BR0015821A (pt) Derivados de pirimidina
DK0758312T3 (da) Substituerede fusionerede og broforbundne bicykliske forbindelser som terapeutiske midler